While obesity-driven inflammation contributes to myocardial remodeling, albumin's anti-inflammatory and endothelial-stabilizing properties, combined with lymphocyte-mediated immune surveillance, may counteract these processes in individuals with optimal PNI. This evidence concerns the gene ALB and obesity disorder.